Nauck, Michael A <br/><br/>
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.  [electronic resource] 

 -  Circulation  Aug 2017 
 - 849-870 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.117.028136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--therapeutic use<br/>Glucagon-Like Peptide 1--metabolism<br/>Glucagon-Like Peptide-1 Receptor--metabolism<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Myocardial Ischemia--prevention & control<br/>Risk Factors<br/>Ventricular Dysfunction--drug therapy<br/>Glucagon-Like Peptide-1 Receptor Agonists